Key Findings
A pre-owned Miltenyi Biotec CliniMACS Instrument Cell Separator (Model 44085) has been made available on LabX.com, a leading online marketplace for laboratory equipment. Manufactured in October 2017, this instrument offers robust capabilities for diverse cell separation requirements across biomedical research and clinical diagnostics.
Technical and Clinical Details
- Instrument Function: The CliniMACS Instrument operates by specifically targeting magnetically labeled cells, enabling the highly efficient separation and enrichment of desired cell populations from complex mixtures, or the precise depletion of unwanted cells. This advanced magnetic cell separation technology yields target cells with exceptional purity.
- Application Areas: This class of cell separation devices is critically important across several advanced biomedical fields, including:
- Regenerative Medicine Research: Essential for the isolation and preparation of stem cells and various immune cell types.
- Cancer Immunotherapy: Key for separating and enriching critical immune cells, such as T cells and Natural Killer (NK) cells, for therapeutic applications.
- Gene Therapy Research: Used for the selection and purification of specific cell populations post-gene introduction.
- Clinical Diagnostics: Employed in the detection of disease marker-bearing cells and for cell preparation workflows in cell therapies.
- Model Information: The specific CliniMACS Instrument listed is Model 44085, with a manufacturing date of October 2017. LabX.com typically furnishes comprehensive details concerning the equipment’s operational condition and included accessories, a crucial aspect for secondary market acquisitions.
Background and Industry Context
Cell separation technology stands as a foundational pillar in modern biotechnology and medical research, proving indispensable for advancing sophisticated cell therapies and novel diagnostic methodologies. Miltenyi Biotec, particularly with its CliniMACS series, has established itself as a leader by consistently delivering GMP-compliant, automated cell processing solutions, earning widespread recognition for its reliability and precision within the industry. The emergence of high-performance, pre-owned equipment on the secondary market presents a pivotal opportunity for research institutions, emerging startups, and smaller laboratories to significantly reduce initial capital expenditure without compromising on technological capability.
Future Outlook
The increased accessibility to such pre-owned, high-caliber instruments plays a crucial role in democratizing access to state-of-the-art cell separation technology. This is particularly impactful for smaller laboratories, academic institutions, and nascent biotech companies operating with constrained budgets. By enabling more widespread adoption of high-quality cell separation devices, the secondary market actively accelerates the pace of cell therapy development and fosters more efficient, impactful research, ultimately contributing to the discovery of transformative new therapies and their more rapid translation to patient care.
Source: https://www.labx.com/item/miltenyi-biotec-clinimacs-instrument-cell-separato/DIS-96958-75996
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime
Comments